Table 6.
Cytokine | Condition∗ | References |
---|---|---|
IL-1β | In vitro, primary microglia culture; LPS and minocycline treated; culture medium quantified (rat) | Wang et al. 2005 [57] |
IL-1β | Ex vivo, STZ treated; LPS and minocycline treated; whole retina homogenate (rat) | Liu et al. 2012 [90, 91]; Yang et al. 2009 [42]; Krady et al. 2005 [56] |
IL-3 | In vivo, vitreous quantified (mouse) | Liu et al. 2012 [90, 91] |
IL-6 | In vivo, vitreous quantified (mouse and human) | Liu et al. 2012 [90, 91]; Abcouwer 2013 [69] |
IL-8 | In vivo, vitreous quantified (mouse and human) | Liu et al. 2012 [90, 91]; Abcouwer 2013 [69] |
IL-10 | In vivo, vitreous quantified (mouse) | Liu et al. 2012 [90, 91] |
IL-12 | In vivo, vitreous quantified (mouse) | Liu et al. 2012 [90, 91] |
IL-18 | Ex vivo, STZ treated; whole retina homogenate (rat) | Yang et al. 2009 [42] |
TNF-α | In vitro, primary microglia culture; LPS and minocycline treated; AGE treated; culture medium quantified (rat) | Wang et al. 2005 [57]; Krady et al. 2005 [56] |
TNF-α | Ex vivo, LPS and minocycline treated; STZ treated; whole retina homogenate (rat) | Yang et al. 2009 [42]; Krady et al. 2005 [56] |
*The condition column represents how cytokine level was quantified, i.e., culture medium collected; whole retina homogenate; or vitreous humor collected and assayed for cytokine production.